Pfizer signs $6 billion licensing deal with China’s 3SBio for cancer drug
HQ Team May 20, 2025: Pfizer Inc. has signed a licensing deal worth about $6 billion with China’s 3SBio to develop, manufacture and.
Drugs
Health
Pharma
Drugs
Health
Pharma
Britain gives green light for GSK Plc’s treatment of rare blood cancer
HQ Team April 18, 2025: Britain’s Medicines and Healthcare products Regulatory Agency has authorised GSK Plc’s combination drug to treat patients with multiple.
Drugs
Health
Pharma
J&J seeks approval for its blood cancer therapy in US, European Union
Johnson & Johnson has submitted regulatory applications to the US drug regulator and European Medicines Agency (EMA) for the extended approval of a blood.
Drugs
Health
Pharma
US drug regulator blocks Regeneron’s blood cancer therapy
The US regulatory body has rejected Regeneron Pharmaceuticals, Inc.,’s blood cancer drug as it did not meet the pre-approval standards of the agency.
Drugs
Health
Pharma
USFDA gives nod to Janssen Research’s blood cancer therapy
The US Food and Drug Administration has approved the Darzalex Faspro combination drug therapy of Janssen Research and Development for treating blood cancer.
Drugs
Health
Pharma
Johnson & Johnson’s blood cancer medicine cleared for bi-weekly use
HQ Team February 21, 2024: Johnson & Johnson announced that USFDA had approved a bi-weekly dose of its blood cancer therapy Tecvayli. The regulatory.
Drugs
Health
Pharma
EMA recommends stopping sale of GSK’s blood cancer drug in EU
The European Medicines Agency has recommended the stoppage of conditional marketing authorisation for GSK’s Blenrep (belantamab mafodotin), a medicine used to treat cancer of.
Drugs
Health
Pharma
US regulator approves Pfizer’s Elrexfio to treat multiple myeloma
HQ Team August 15, 2023: The USFDA has granted accelerated approval for Pfizer Inc’s Elrexfio to treat incurable blood cancer, multiple myeloma, that.
Drugs
Health
Pharma
USFDA green lights Janssen’s Talvey to treat multiple myeloma
HQ Team August 11, 2023: The USFDA has granted accelerated approval to Janssen Pharmaceutical Companies for its cancer antibody treatment, Talvey, to treat.
Drugs
Pharma
US court dismisses antitrust claims against Dr. Reddy’s cancer drug
A US court dismissed all claims against Dr. Reddy's Laboratories Inc., a wholly-owned subsidiary, in an antitrust complaint related to the cancer drug.